Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age12-20
SponsorChildren's Mercy Hospital Kansas City

About this trial

This is a single-site open label non-randomized study comparing effects of sequential versus continuous use of progesterone supplementation amongst Turner Syndrome (TS) patients with primary ovarian insufficiency (POI) prescribed hormone replacement therapy (HRT).

Eligibility criteria

Qualifiers

Diagnosis of Turner Syndrome and Primary Ovarian Insufficiency.

Prescribed adult dosing* of transdermal or oral estradiol for estrogen replacement therapy.

Have achieved menarche.

Disqualifiers

Disclosure of sexual activity and desire for contraception.

Having a levonorgestrel-releasing intrauterine device or etonogestrel arm implant in place.

Having received depot medroxyprogesterone within one year prior to study recruitment.

Non-English or non-Spanish speaking.

Trial design

Treatments tested in this trial

  • Micronized progesterone 200 MG
  • Micronized Progesterone 100 MG

Treatment groups

40 Participants
are divided into 2 treatment groups